ClinConnect ClinConnect Logo
Search / Trial NCT07146204

First in Human Trial of R-Star: A Novel Robotic System for Minimally Invasive Coronary Artery Procedures.

Launched by ROBOCATH ยท

Trial Information

Current as of September 29, 2025

Not yet recruiting

Keywords

Coronary Artery Disease Percutaneous Coronary Intervention Robotic Assisted Percutaneous Coronary Intervention

ClinConnect Summary

This clinical trial is testing a new robotic system called R-Star to see if it can safely and effectively help doctors open blocked heart arteries in adults with coronary artery disease. The procedure, called percutaneous coronary intervention (PCI), is usually done by hand, but this study wants to find out if the robot can perform it without problems and if it can successfully open the artery without causing complications.

Adults between the ages of 65 and 74 who are already scheduled for a planned PCI might be eligible to join. Before the procedure, participants will have some tests like a medical exam, blood work, and heart monitoring to make sure they qualify. During the study, the R-Star robot will be used to perform the artery-opening procedure, with imaging done before and after to check the results. Afterward, participants will have follow-up visits before leaving the hospital and about a month later to make sure they are healing well and to gather information about how the robot performed. The trial is not yet recruiting participants but aims to learn if this robotic system could be a safe and helpful tool for treating coronary artery disease in the future.

Gender

ALL

Eligibility criteria

About Robocath

Robocath is a pioneering medical technology company focused on transforming cardiovascular interventions through advanced robotics. Specializing in the development of innovative robotic systems for the treatment of coronary and peripheral artery diseases, Robocath aims to enhance the precision, safety, and efficiency of vascular procedures. By leveraging cutting-edge robotics and artificial intelligence, the company seeks to empower healthcare professionals with tools that improve patient outcomes while minimizing procedural risks. Committed to clinical excellence, Robocath actively engages in research and clinical trials to validate the effectiveness of its technologies in real-world applications.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported